EurekaMag.com logo
+ Site Statistics
References:
53,214,146
Abstracts:
29,074,682
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Identification of larval-stage-specific antigens of Onchocerca volvulus uniquely recognized by putative immune sera from humans and vaccination sera from animal models






Annals of Tropical Medicine and Parasitology 91(1): 67-77

Identification of larval-stage-specific antigens of Onchocerca volvulus uniquely recognized by putative immune sera from humans and vaccination sera from animal models

Immunity to Onchocerca volvulus is indicated by the existence of putative immune individuals (PI), who do not develop patent infections or clinical symptoms after living in endemic areas for extended periods of time. To gain insight into the nature of the humoral response of PI from Liberia and Ecuador, their sera and those of infected individuals were investigated and compared using western blots. The antigen preparations used were extracts of third- and fourth-stage larvae (L3 and L4, respectively), excretory-secretory proteins (ES-L3) and extracts of third-stage larvae (L3-day2) that had been cultured for 2 days, and extracts of nodular and skin microfilariae. Whereas some antigens were commonly recognized by all individuals, many stage-specific antigens (of 68, 60, 55, 46, 43, 42, 20 and 18 kDa in L3; 100, 88, 80, 50, 48, 45, 40 and 20 kDa in L3-day2; 110, 80 and 72 kDa in ES-L3; 48, 18, 16 and 14 kDa in L4; and 115, 60, 47, 43 and 17 kDa in skin and/or nodular microfilariae) were uniquely recognized by sera from PI. Some of the unique antigens were also recognized by sera from mice and a chimpanzee that were resistant to challenge after immunization with irradiated third-stage larvae. The results support the validity of the assumption that a unique status of immunity develops in certain individuals living in areas where onchocerciasis is endemic.

(PDF same-day service: $19.90)

Accession: 002863553

PMID: 9093431

DOI: 10.1080/00034983.1997.11813113



Related references

Identification of an onchocerca volvulus complementary dna encoding a low molecular weight antigen uniquely recognized by onchocerciasis patient sera. Molecular & Biochemical Parasitology 39(1): 135-146, 1990

Identification of an Onchocerca volvulus cDNA encoding a low-molecular-weight antigen uniquely recognized by onchocerciasis patient sera. Molecular and Biochemical Parasitology 39.1: 135-146, 1990

Identification of larval-stage antigens of ascaris suum recognized with immune sera from pigs. Journal of Veterinary Medical Science 63(6): 683-685, 2001

Complementary dna clones encoding low molecular weight antigens onchocerca volvulus are recognized by human sera from onchocerciasis but not bancroftian filariasis patients. Acta Leidensia 59(1-2): 470, 1990

Immunity to onchocerciasis: recognition of larval antigens by humans putatively immune to Onchocerca volvulus infection. Journal of Infectious Diseases 163(5): 1128-1133, 1991

Immunity to onchocerciasis preferential recognition of larval antigens by humans putatively immune to onchocerca volvulus infection. Clinical Research 37(2): 436A, 1989

Antigens of Cryptosporidium sporozoites recognized by immune sera of infected animals and humans. Journal of Parasitology 74(1): 135-143, 1988

Identification and stage-specific expression of two putative P-glycoprotein coding genes in Onchocerca volvulus. Molecular and Biochemical Parasitology 102(2): 273-281, 1999

Human immune responses to infective stage larval-specific chitinase of filarial parasite, Onchocerca volvulus, Ov-CHI-1. Filaria Journal 2(6): (14 March 2003), 2003

Epitopes of the Onchocerca volvulus RAL1 antigen, a member of the calreticulin family of proteins, recognized by sera from patients with onchocerciasis. Infection and Immunity 62(9): 3696-3704, 1994